$ANIK
Anika Therapeutics, Inc.

2015 Q2 Form 10-Q Financial Statement

#000117184315004303 Filed on August 04, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2014 Q2
Revenue $22.90M $26.28M
YoY Change -12.83% 26.15%
Cost Of Revenue $5.274M $5.333M
YoY Change -1.11% -15.5%
Gross Profit $17.62M $15.93M
YoY Change 10.61% 9.76%
Gross Profit Margin 76.95% 60.64%
Selling, General & Admin $3.388M $3.866M
YoY Change -12.36% 13.68%
% of Gross Profit 19.22% 24.26%
Research & Development $1.812M $1.873M
YoY Change -3.26% 2.41%
% of Gross Profit 10.28% 11.76%
Depreciation & Amortization $920.0K $1.170M
YoY Change -21.37% 9.35%
% of Gross Profit 5.22% 7.34%
Operating Expenses $5.200M $5.739M
YoY Change -9.39% 9.74%
Operating Profit $12.43M $15.20M
YoY Change -18.24% 61.76%
Interest Expense $24.00K $5.935K
YoY Change 304.38% -116.31%
% of Operating Profit 0.19% 0.04%
Other Income/Expense, Net
YoY Change
Pretax Income $12.45M $15.21M
YoY Change -18.12% 62.45%
Income Tax $4.634M $5.906M
% Of Pretax Income 37.21% 38.84%
Net Earnings $7.820M $9.302M
YoY Change -15.93% 57.8%
Net Earnings / Revenue 34.14% 35.4%
Basic Earnings Per Share $0.52 $0.63
Diluted Earnings Per Share $0.51 $0.60
COMMON SHARES
Basic Shares Outstanding 14.96M 14.69M
Diluted Shares Outstanding 15.34M 15.49M

Balance Sheet

Concept 2015 Q2 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $122.4M $84.90M
YoY Change 44.17% 56.93%
Cash & Equivalents $103.9M $84.88M
Short-Term Investments $18.50M
Other Short-Term Assets $2.400M $1.600M
YoY Change 50.0% -44.83%
Inventory $11.72M $13.90M
Prepaid Expenses
Receivables $19.17M $19.20M
Other Receivables $0.00 $0.00
Total Short-Term Assets $155.7M $119.5M
YoY Change 30.31% 38.19%
LONG-TERM ASSETS
Property, Plant & Equipment $31.52M $32.40M
YoY Change -2.71% -4.27%
Goodwill $7.611M
YoY Change
Intangibles $13.08M
YoY Change
Long-Term Investments
YoY Change
Other Assets $100.0K $100.0K
YoY Change 0.0% -50.0%
Total Long-Term Assets $52.29M $59.60M
YoY Change -12.27% -3.75%
TOTAL ASSETS
Total Short-Term Assets $155.7M $119.5M
Total Long-Term Assets $52.29M $59.60M
Total Assets $208.0M $179.1M
YoY Change 16.14% 20.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.658M $2.200M
YoY Change -24.65% -18.51%
Accrued Expenses $4.442M $4.900M
YoY Change -9.35% 8.8%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.957M $7.300M
YoY Change 9.0% -37.61%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $779.7K $1.100M
YoY Change -29.12% -13.0%
Total Long-Term Liabilities $779.7K $1.100M
YoY Change -29.12% -87.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.957M $7.300M
Total Long-Term Liabilities $779.7K $1.100M
Total Liabilities $8.737M $16.70M
YoY Change -47.68% -17.19%
SHAREHOLDERS EQUITY
Retained Earnings $116.2M
YoY Change
Common Stock $80.66M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $190.6M $162.4M
YoY Change
Total Liabilities & Shareholders Equity $208.0M $179.1M
YoY Change 16.14% 20.69%

Cashflow Statement

Concept 2015 Q2 2014 Q2
OPERATING ACTIVITIES
Net Income $7.820M $9.302M
YoY Change -15.93% 57.8%
Depreciation, Depletion And Amortization $920.0K $1.170M
YoY Change -21.37% 9.35%
Cash From Operating Activities $10.90M $4.240M
YoY Change 157.08% 19.1%
INVESTING ACTIVITIES
Capital Expenditures -$870.0K -$400.0K
YoY Change 117.5% 471.43%
Acquisitions
YoY Change
Other Investing Activities -$6.020M $0.00
YoY Change -100.0%
Cash From Investing Activities -$6.890M -$400.0K
YoY Change 1622.5% -1100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -1.180M
YoY Change -100.0% 180.95%
NET CHANGE
Cash From Operating Activities 10.90M 4.240M
Cash From Investing Activities -6.890M -400.0K
Cash From Financing Activities 0.000 -1.180M
Net Change In Cash 4.010M 2.660M
YoY Change 50.75% -16.35%
FREE CASH FLOW
Cash From Operating Activities $10.90M $4.240M
Capital Expenditures -$870.0K -$400.0K
Free Cash Flow $11.77M $4.640M
YoY Change 153.66% 27.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
CY2015Q2 anik Accrued Clinical Trial Costs Current
AccruedClinicalTrialCostsCurrent
421502
CY2014Q4 anik Accrued Clinical Trial Costs Current
AccruedClinicalTrialCostsCurrent
508042
CY2015Q2 anik Accrued Research Grants Current
AccruedResearchGrantsCurrent
492001
CY2014Q4 anik Accrued Research Grants Current
AccruedResearchGrantsCurrent
539053
CY2015Q2 anik Currency Translation Adjustment
CurrencyTranslationAdjustment
-4930216
CY2015Q2 anik Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
69016
CY2014Q4 anik Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
69042
CY2015Q2 anik Intangible Assets Completed Projects Amount
IntangibleAssetsCompletedProjectsAmount
CY2015Q2 anik Intangible Assets Gross Carrying Amount
IntangibleAssetsGrossCarryingAmount
28902686
CY2015Q2 anik Percentage Of Net Revenue
PercentageOfNetRevenue
1
CY2014Q2 anik Percentage Of Net Revenue
PercentageOfNetRevenue
1
anik Percentage Of Net Revenue
PercentageOfNetRevenue
1
anik Percentage Of Net Revenue
PercentageOfNetRevenue
1
anik Share Based Compensation Arrangement By Share Based Payment Award Contractual Term Range
ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTermRange
P10Y
anik Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodTotalIntrinsicValue
2990912
anik Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodTotalIntrinsicValue
25396552
CY2015Q2 anik Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingIntrinsicValue
13900000
anik Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm
P6Y292D
CY2015Q2 anik Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsWeightedAverageExercisePrice
17.86
CY2015Q2 anik Share Based Compensation Arrangement By Shareb Bsed Payment Award Options And Stock Appreciation Rights Outstanding Number
ShareBasedCompensationArrangementBySharebBsedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber
825897
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Document Period End Date
DocumentPeriodEndDate
2015-06-30
CY2015Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
80505021
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
77539699
CY2015Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
509352
CY2014Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
377960
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1063949
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
805782
CY2015Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
133820
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
146618
CY2015Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14632113
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Voluntary Filers
EntityVoluntaryFilers
No
dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2015Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1657683
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1201226
CY2015Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
19166116
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17152028
CY2015Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1821898
CY2014Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
CY2015Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4441785
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4747526
CY2015Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
742319
CY2014Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
553630
CY2015Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
23148636
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21950706
CY2015Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-6326442
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-4494800
CY2015Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
265508
CY2014Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
536226
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
535780
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1074561
CY2015Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
238472
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
207839
CY2014Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
67820
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
113301
CY2015Q2 us-gaap Assets
Assets
208012150
CY2014Q4 us-gaap Assets
Assets
193996376
CY2015Q2 us-gaap Assets Current
AssetsCurrent
155725537
CY2014Q4 us-gaap Assets Current
AssetsCurrent
139025042
CY2015Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
18513150
CY2015Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
CY2015Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
4920
CY2015Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
18518070
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
103920222
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
100155864
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
63333160
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
84879562
CY2014Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
72551754
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3764358
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
21546402
CY2015Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15003694
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14851703
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15003694
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14851703
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
150037
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
148517
CY2015Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8237043
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9111611
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9503472
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
24115748
CY2015Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
5274059
CY2014Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
5332913
us-gaap Cost Of Goods Sold
CostOfGoodsSold
9587499
us-gaap Cost Of Goods Sold
CostOfGoodsSold
9693932
CY2015Q2 us-gaap Costs And Expenses
CostsAndExpenses
10474873
CY2014Q2 us-gaap Costs And Expenses
CostsAndExpenses
11071947
us-gaap Costs And Expenses
CostsAndExpenses
20490736
us-gaap Costs And Expenses
CostsAndExpenses
21211666
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-428312
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-357081
CY2015Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
35938
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
24510
CY2015Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
74371
CY2014Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
102192
CY2015Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
1459867
CY2014Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
1188768
CY2015Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0
CY2015Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
8633398
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
8929890
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1827070
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2366411
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.76
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.67
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.51
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.60
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.74
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.57
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-120447
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
65928
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.37
CY2015Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.37
CY2014Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.39
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.38
CY2015Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2260469
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2791935
CY2015Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
4700000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y346D
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
933863
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
9308113
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
933863
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
9308113
CY2015Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-10888563
CY2015Q2 us-gaap Goodwill
Goodwill
7610821
CY2014Q4 us-gaap Goodwill
Goodwill
8338699
CY2013Q4 us-gaap Goodwill
Goodwill
9443894
us-gaap Goodwill Translation Adjustments
GoodwillTranslationAdjustments
-727878
CY2014 us-gaap Goodwill Translation Adjustments
GoodwillTranslationAdjustments
-1105195
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12452595
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
15208648
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
17980779
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
39079683
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4633038
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6645665
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5906298
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14747080
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
559363
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-943169
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2389372
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
191088
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
3193594
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
7014770
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-263692
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-749411
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-5480
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2140902
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-496543
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3030077
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-97679
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-99980
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-458857
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
10624
CY2015Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13083907
CY2014Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
14894710
CY2015Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
23907
CY2014Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
5935
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
47630
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
6402
CY2015Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3137849
CY2014Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3204186
CY2015Q2 us-gaap Inventory Net
InventoryNet
11718243
CY2014Q4 us-gaap Inventory Net
InventoryNet
12406776
CY2015Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
5422506
CY2014Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
6161363
CY2015Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3157888
CY2014Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3041227
us-gaap Inventory Write Down
InventoryWriteDown
67863
us-gaap Inventory Write Down
InventoryWriteDown
147693
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
208012150
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
193996376
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
7957304
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5973262
CY2015Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
18513150
CY2014Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
6750000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
17836814
us-gaap Net Income Loss
NetIncomeLoss
11335114
us-gaap Net Income Loss
NetIncomeLoss
24332603
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
7819557
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1902892
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4321018
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12902042
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-677358
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14883955
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
9302350
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
12428688
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
15202713
us-gaap Operating Income Loss
OperatingIncomeLoss
17933149
us-gaap Operating Income Loss
OperatingIncomeLoss
39073281
CY2015Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
525494
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
354866
CY2015Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-3198
CY2014Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-3198
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
CY2015Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
420684
CY2014Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-190739
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1828444
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-216855
CY2015Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
417486
CY2014Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-190739
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1831642
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-216855
CY2015Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
779666
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
893935
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6348900
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
22018070
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1133972
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
677358
CY2015Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1250000
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1250000
CY2015Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2015Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
947939
CY2014Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
804985
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
398857
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
927515
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
959305
CY2015Q2 us-gaap Prepaid Taxes
PrepaidTaxes
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
116238795
CY2014Q4 us-gaap Prepaid Taxes
PrepaidTaxes
412301
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
10250000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
CY2015Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5448
CY2014Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
294106
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
969029
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1361805
CY2015Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
0
CY2014Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
0
CY2015Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
54671505
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
53619589
CY2015Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31522869
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31668883
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1812320
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1873158
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3910082
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4160873
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
104903681
CY2015Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
22898032
CY2014Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
21267156
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
38412714
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
35618561
CY2015Q2 us-gaap Sales Revenue Net
SalesRevenueNet
22903561
CY2014Q2 us-gaap Sales Revenue Net
SalesRevenueNet
26274660
us-gaap Sales Revenue Net
SalesRevenueNet
38423885
us-gaap Sales Revenue Net
SalesRevenueNet
60284947
CY2015Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
5529
CY2014Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
5007504
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
11171
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
24666386
CY2015Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3388494
CY2014Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3865876
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6993155
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7356861
us-gaap Share Based Compensation
ShareBasedCompensation
1063949
us-gaap Share Based Compensation
ShareBasedCompensation
805782
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5328
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
7500
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
111625
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y182D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y
CY2014Q2 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
133774
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
190567411
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
178097097
CY2015Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
374251
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15335687
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15492732
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15332391
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15487432
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14961436
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14687747
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14933534
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14559917

Files In Submission

Name View Source Status
0001171843-15-004303-index-headers.html Edgar Link pending
0001171843-15-004303-index.html Edgar Link pending
0001171843-15-004303.txt Edgar Link pending
0001171843-15-004303-xbrl.zip Edgar Link pending
anik-20150630.xml Edgar Link completed
anik-20150630.xsd Edgar Link pending
anik-20150630_cal.xml Edgar Link unprocessable
anik-20150630_def.xml Edgar Link unprocessable
anik-20150630_lab.xml Edgar Link unprocessable
anik-20150630_pre.xml Edgar Link unprocessable
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gfpf10q_080415.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending